Replimune Group Inc. is a biotechnology company focused on developing oncolytic immunotherapies for the treatment of cancer, combining immuno-oncology science with viral therapy.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!